Found: 1

Select item for more details and to access through your institution.

  • RH5.1-CyRPA-Ripr antigen combination vaccine shows little improvement over RH5.1 in a preclinical setting.

    Published in:
    Frontiers in Cellular & Infection Microbiology, 2022, v. 12, p. 1, doi. 10.3389/fcimb.2022.1049065
    By:
    • Healer, Julie;
    • Thompson, Jennifer K.;
    • Mackwell, Karen L.;
    • Browne, Cecille D.;
    • Seager, Benjamin A.;
    • Ngo, Anna;
    • Lowes, Kym N.;
    • Silk, Sarah E.;
    • Pulido, David;
    • King, Lloyd D. W.;
    • Christen, Jayne M.;
    • Noe, Amy R.;
    • Kotraiah, Vinayaka;
    • Masendycz, Paul J.;
    • Rajagopalan, Rajkannan;
    • Lucas, Leanne;
    • Stanford, Marianne M.;
    • Soisson, Lorraine;
    • Diggs, Carter;
    • Miller, Robin
    Publication type:
    Article